Pharmaceuticals Headlines from PR Newswire

< Go Back

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation
Valeant Awards Winners of Second Annual I Acanya® Succeed Scholarship Program $48,000 Each Toward College Tuition
Janssen Pharmaceuticals, Inc. Announced As NASCAR Sprint Cup Series™ Event Entitlement Partner At Chicagoland Speedway
DigiPath No New Corporate Developments
Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
Access Pharmaceuticals Featured On
PCI Announces Definitive Agreement to Acquire Penn Pharma
Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
CHMP Recommends Approval of Lilly's Humalog® 200 units/ml KwikPen®
Report: Biopharma and Medical Device Companies Beat Historic Investment Returns
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion™ in the new facility.
Hospira Reports Second-Quarter 2014 Results
Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 English
PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Intouch Solutions Launches SocialQueue™, A Real-Time Social Monitoring Tool For Pharma
Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME)
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
Pfenex Announces Closing of Initial Public Offering
Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million English
Edwards Lifesciences Reports Strong Second Quarter Results
QIAGEN Reports Second Quarter and First Half 2014 Results and Announces Launch of new $100 Million Share Repurchase Program
GSK's Tanzeum™ is now available in pharmacies in the U.S.
Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity
New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
ISPE Hires Healthcare Association Exec as CEO
Drew Crawford Announces Launch of PBM365 Media
Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo
Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology
Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform English
China Biologic to Report Second Quarter 2014 Financial Results
Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
There's Something in the Water: Global Icon, Berocca®, Arrives on U.S. Soil with New Special Formula and Flavor
A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market
Ambit Biosciences To Announce Second Quarter 2014 Financial Results
Phosphagenics Provides Update on Opioid Patch Program
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results
Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer

< Prev Next >
PR Newswire - United Business Media